Clinical trial
ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia- CeGAL-IPC 2014-012
NCT02619071 is registered in ClinicalTrials.gov with Institut Paoli-Calmettes as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ChEmo-Genomics Based Treatment of Acute Myeloid Leukemia- CeGAL-IPC 2014-012
- Lead sponsor
- Institut Paoli-Calmettes
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2015
- Completion date
- August 31, 2017
- Enrollment
- 87 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.